Showing results (231-240 of 372) with videos related to
Sort By:
Pageof 38
Age and Ageing|March 19, 2023
Cluster randomised trial of a complex interprofessional intervention (interprof ACT) to reduce hospital admission of nursing home residentsAna Mazur, Britta Tetzlaff, Tina Mallon, et al.Acta Neuropathologica|January 18, 2020
Antibody signatures in patients with histopathologically defined multiple sclerosis patternsLidia Stork, David Ellenberger, Klemens Ruprecht, et al.Neurology|May 11, 2016
Monitoring of 30 marker candidates in early Parkinson disease as progression markersBrit Mollenhauer, Johannes Zimmermann, Friederike Sixel-Döring, et al.Trials|November 6, 2020
Effects of strategies to improve general practitioner-nurse collaboration and communication in regard to hospital admissions of nursing home residents (interprof ACT): study protocol for a cluster randomised controlled trialChristiane Müller, Berit Hesjedal-Streller, Nina Fleischmann, et al.European Heart Journal. Acute Cardiovascular Care|July 30, 2020
Long-term effects of a standardized feedback-driven quality improvement program for timely reperfusion therapy in regional STEMI care networksKarl Heinrich Scholz, Björn Lengenfelder, Claudius Jacobshagen, et al.Scientific Reports|April 27, 2022
A machine learning algorithm for electrocardiographic fQRS quantification validated on multi-center dataAmalia Villa, Bert Vandenberk, Tuomas Kenttä, et al.Neurology(R) Neuroimmunology & Neuroinflammation|February 20, 2016
Serum peptide reactivities may distinguish neuromyelitis optica subgroups and multiple sclerosisImke Metz, Tim Beißbarth, David Ellenberger, et al.ESC Heart Failure|May 12, 2026
Effect of anti-fibrotic therapy on regression of myocardial fibrosis after TAVI: Design and rationale of the Reduce-MFA DZHK25 trialMiriam Puls, Elisabeth M Zeisberg, Marius Placzek, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|November 4, 2024
Treatment effect modifiers of immunotherapies for relapsing-remitting multiple sclerosis-A systematic review and meta-analysisChristoph Heesen, Christian Röver, Susanna Salem, et al.Nature Reviews. Drug Discovery|July 13, 2026
Design, simulate, refine: simulation-guided clinical trials for accelerated drug developmentElias Laurin Meyer, Tim Friede, Andrew P Grieve, et al.Pageof 38